Koh Hock Peng, Ab Jalal Haliza, Koo Yee Ping, Chen Mary Siew Yng, Selvaratanam Manimegahlai, Bhuvanendran Pillai Anaanthan, Wong Wai Kit, Guee Xin Nee, Tan Sherene Su Ann, Tan Shirlyn, Teh Lih Jiuan, Sia Rosalind Guen Lin
Pharmacy Department, Ministry of Health Malaysia, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Pharmacy Department, Ministry of Health Malaysia, Hospital Sultanah Aminah, Johor Bahru, Malaysia.
J Pharm Policy Pract. 2025 Jan 27;18(1):2457410. doi: 10.1080/20523211.2025.2457410. eCollection 2025.
The emergency medicine (EM) pharmacist is an integrated part of the Emergency Department (ED) interdisciplinary team in many countries, including Malaysia. The presence of EM pharmacists in the ED has positively impacted patient outcomes. Data on EM pharmacists' interventions is scarce in the Asian region. In Malaysia, data on interventions done by EM pharmacists in the EDs was unavailable. This study aimed to assess the type of interventions done by EM pharmacists in the ED of tertiary public hospitals in Malaysia.
This cross-sectional, multicenter study involved EM pharmacists from 14 tertiary hospitals in Malaysia. All accepted interventions done by EM pharmacists in the ED for patients admitted to the Red (critical) and Yellow (semi-critical) zones from January to June 2022 were extracted from the Clinical Pharmacy Report Form. All data were analyzed descriptively.
The EM pharmacists documented 1659 accepted interventions on 1584 patients during the study period. Inappropriate regimens ( = 1117, 67.3%) and incomplete prescriptions ( = 339, 20.4%) were the main categories of accepted interventions in ED. Inappropriate drug ( = 574, 34.6%), dose ( = 292, 17.6%), and frequency ( = 176, 10.6%) were the top three subcategory interventions documented under inappropriate regimens. Antimicrobials, antihypertensives, and proton pump inhibitors were the commonest drug intervened under the categories of inappropriate drug intervention. There were 272 (16.4%) accepted interventions on high-alert medications (HAMs). Insulin, enoxaparin, and noradrenaline were the most intervened HAMs.
Inappropriate treatment regimens were the most common intervention category done by EM pharmacists in Malaysia. The significant number of interventions done by EM pharmacists demonstrated the importance of EM pharmacists as integral members of the EM team. This data can help improve the quality of clinical pharmacy services in the ED and is important for the future expansion of clinical pharmacy services in all EDs across Malaysia, neighbouring countries, and other developing countries.
在包括马来西亚在内的许多国家,急诊医学(EM)药剂师是急诊科(ED)跨学科团队不可或缺的一部分。急诊医学药剂师在急诊科的存在对患者治疗结果产生了积极影响。亚洲地区关于急诊医学药剂师干预措施的数据很少。在马来西亚,急诊医学药剂师在急诊科所做干预措施的数据也无法获取。本研究旨在评估马来西亚三级公立医院急诊科急诊医学药剂师所做干预措施的类型。
这项横断面、多中心研究涉及马来西亚14家三级医院的急诊医学药剂师。2022年1月至6月期间,急诊医学药剂师在急诊科对收入红色(危急)和黄色(半危急)区域患者所做的所有已接受干预措施均从临床药学报告表中提取。所有数据均进行描述性分析。
在研究期间,急诊医学药剂师记录了对1584名患者的1659项已接受干预措施。不适当治疗方案(n = 1117,67.3%)和处方不完整(n = 339,20.4%)是急诊科已接受干预措施的主要类别。不适当药物(n = 574,34.6%)、剂量(n = 292,17.6%)和频次(n = 1,76,10.6%)是不适当治疗方案下记录的前三大子类别干预措施。抗菌药物、抗高血压药物和质子泵抑制剂是不适当药物干预类别下最常被干预的药物。对高警示药物(HAMs)有272项(16.4%)已接受干预措施。胰岛素、依诺肝素和去甲肾上腺素是最常被干预的高警示药物。
不适当治疗方案是马来西亚急诊医学药剂师最常见的干预类别。急诊医学药剂师所做的大量干预措施表明了急诊医学药剂师作为急诊团队不可或缺成员的重要性。这些数据有助于提高急诊科临床药学服务质量,对于马来西亚所有急诊科、邻国及其他发展中国家未来临床药学服务的扩展具有重要意义。